Ex-FDA Head Says AbbVie Promoted Off-Label Androgel Use

By Jessica Corso (June 6, 2017, 5:40 PM EDT) -- Former U.S. Food and Drug Administration Commissioner David Kessler told jurors Tuesday that he felt AbbVie Inc. had stepped outside the bounds placed on it by the FDA by promoting testosterone replacement therapy drug Androgel for use in aging men without testing the safety of the drug....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!